Yaohai Bio-pharmaceutical Co., Ltd

Booth 2275
Taizhou, Jiangsu, China
Yaohai Bio-Pharma is China's first and largest biologics CRDMO (Contract Research, Development and Manufacturing Organization) focusing on microbial expression systems. It provides customized end-to-end solutions from DNA design and synthesis, microbial strain engineering and construction to drug substance manufacturing in GMP or non-GMP level and products fill & finish across diversified modalities, such as recombinant proteins, peptides and polypeptides, enzymes, single-domain antibodies (sdAbs), plasmid DNA and mRNA, glyco-polymers, virus-like particles (VLPs), to meet global customers’ clinical and commercial needs in biological drugs, biosimilars, vaccines and diagnostics for human and veterinary use.

Yaohai Bio-Pharma is actively building an alliance with independent and corporate partners to boost its international business development. Partners can leverage their industry connections to introduce relevant clients or new partners to the company, and the latter will offer commissions on any resulting business.